Gly-Sal 5-2

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Gly-Sal 5-2
Generic name: SALICYLIC ACID
Manufacturer: Topiderm, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: a75e4cee-678f-4e44-9e5e-bafae1c23f9b
SPL ID: b72df2c6-2e93-4daf-8bf9-057b17f31bbc
Version: 1
Effective date: 2024-07-31
Source export date: 2026-10-30
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/9abf0f8b126f8aad070e21ea702bfb5e39ce670b16ae57dd52e8877705d1bf5d/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:31:48

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Gly-Sal 5-2	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		Topiderm, Inc.	openfda.manufacturer_name
ndc	package	51326-927-01	openfda.package_ndc
ndc	product	51326-927	openfda.product_ndc
ndc11	package	51326092701	derived:openfda.package_ndc
rxcui		562600	openfda.rxcui
spl id		b72df2c6-2e93-4daf-8bf9-057b17f31bbc	id
spl set id		a75e4cee-678f-4e44-9e5e-bafae1c23f9b	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Keep away from eyes, lips, and mouth. Using other topical medications, while using this product or immediately thereafter, may increase dryness or irritation. If this occurs discontinue use and see your doctor. Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center. Sunscreen use is recommended with any glycolic acid product and for an additional week thereafter because some individuals may be more sensitive to sunlight.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.